echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > "Neuron" Alzheimer's disease: Inflammatory markers evident in early stages

    "Neuron" Alzheimer's disease: Inflammatory markers evident in early stages

    • Last Update: 2022-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent years, evidence has shown that the brain's immune system and related inflammatory processes -- also known as "neuro-inflammation" -- contribute significantly to the development of Alzheimer's disease
    .


    With this in mind, the scientists analyzed various immune biomarkers, characterized by good detection power and reproducible results in the cerebrospinal fluid


    "We found that some of these markers of inflammation were evident even in the absence of symptoms of dementia," Heneka said
    .


    "Based on the data we have at the moment, we can't be sure about the delivery time


    extensive database

    The starting point for the investigation was data from the so-called DELCODE study, in which the DZNE is working with several German university hospitals to study dementia and its early stages
    .


    The current research project includes findings from 300 men and women over the age of 60


    Onset even without dementia

    "Biomarkers for amyloid and tau have been established
    .


    These proteins accumulate in the brains of Alzheimer's patients and can also be detected in the cerebrospinal fluid


    Evidence for neuroprotection

    Two of the markers -- proteins belonging to the "TAM receptor family" -- appear to be involved in damage control programs
    .


    Among the study participants with high marker levels, who had relatively larger brain volumes, cognitive function declined more slowly over time


    "Inflammatory processes are not bad per se, but are a normal protective response of the immune system to threatening stimuli, especially at the beginning
    .


    But they shouldn't last too long, so they need to be regulated," Heneka said


    Frederic Brosseron, Anne Maass, Luca Kleineidam, Kishore Aravind Ravichandran, Pablo García González, Róisín M.


    McManus, Christina Ising, Francesco Santarelli, Carl-Christian Kolbe, Lisa M.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.